Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $77.7 million.

  • Fractyl Health's Cash & Equivalents fell 822.55% to $77.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.7 million, marking a year-over-year decrease of 822.55%. This contributed to the annual value of $67.5 million for FY2024, which is 7857.54% up from last year.
  • Fractyl Health's Cash & Equivalents amounted to $77.7 million in Q3 2025, which was down 822.55% from $22.3 million recorded in Q2 2025.
  • In the past 5 years, Fractyl Health's Cash & Equivalents ranged from a high of $121.4 million in Q1 2024 and a low of $22.3 million during Q2 2025
  • Its 3-year average for Cash & Equivalents is $68.9 million, with a median of $72.6 million in 2024.
  • As far as peak fluctuations go, Fractyl Health's Cash & Equivalents surged by 10314.97% in 2024, and later tumbled by 7823.09% in 2025.
  • Quarter analysis of 3 years shows Fractyl Health's Cash & Equivalents stood at $33.2 million in 2023, then surged by 103.15% to $67.5 million in 2024, then rose by 15.17% to $77.7 million in 2025.
  • Its Cash & Equivalents was $77.7 million in Q3 2025, compared to $22.3 million in Q2 2025 and $42.1 million in Q1 2025.